InjectionInjection
Schedule H (Prescription Required)Anaesthetics & Local NumbingCode: 356

Lignocaine Injection 2% w/v

Generic Formulation:Lignocaine Injection IP 2% w/v
Pack Size:30 ml Vial
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹17.53
Brand Estimate*
₹977.2
Estimated Savings:₹959.67 (98% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Lignocaine (Lidocaine) Hydrochloride is the gold-standard amino-amide local anesthetic and Class Ib antiarrhythmic agent on the WHO Model List of Essential Medicines. It reversibly blocks voltage-gated sodium channels in neuronal cell membranes, stopping the generation and propagation of pain signals. When combined with Adrenaline (Epinephrine 1:80,000), localized vasoconstriction reduces surgical bleeding, slows systemic anesthetic absorption, and doubles the duration of local anesthesia. Indicated for infiltration anesthesia, regional nerve blocks, epidural anesthesia, and treatment of acute ventricular arrhythmias.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 356.Report inaccuracy

Usage Guidelines

Administered by a licensed healthcare professional by local infiltration, nerve block, or IV infusion under sterile conditions. Always aspirate before injection to verify no vascular penetration. Lignocaine with Adrenaline must NEVER be injected into end-artery structures (fingers, toes, nose, ears, penis) due to risk of ischemic necrosis.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Local numbness, stinging at injection site, transient dizziness. Rare/Severe: Local Anesthetic Systemic Toxicity (LAST: perioral numbness, tinnitus, muscle twitching, seizures, cardiovascular collapse), anaphylaxis, and ischemic tissue necrosis with adrenaline.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Strictly avoid formulations with Adrenaline in end-artery appendages (digits, ears, nose, penis) due to gangrene risk. Toxic doses or accidental IV injection causes LAST; have lipid emulsion and resuscitation equipment ready. Caution in cardiac arrhythmias and severe liver disease.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.